Press Releases
Oxford, UK, 17 Jun 2019 – Celleron Therapeutics, a UK-based company developing personalised medicines for cancer patients, announced today approval
Read MoreOxford UK, 15 June 2019 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, announced today that
Read MoreOxford, UK, 22 May 2019 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, participated in the
Read MoreOxford, UK, 16 April 2019 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, announced today the
Read MoreOxford, UK, 21 March 2019 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, announce today a
Read MoreOxford, UK, 16 March 2019 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, held a cake
Read MoreOxford, UK, February 2019 – Celleron Therapeutics, the UK-based company developing personalised medicines for cancer patients, on World Cancer Day
Read MoreCelleron Therapeutics Successfully Completes Safety Evaluation of Pioneering Combination Therapy Approach to Treating Colorectal Cancer Oxford, UK, 14th January 2019
Read MoreCelleron Therapeutics appoints Simon Cook as its Clinical Research Director Oxford 14 January 2019; Celleron Therapeutics Limited, the UK based
Read MoreOxford 20th December 2018 – Celleron Therapeutics Limited, the UK based precision cancer medicines company, developing novel small molecule therapeutics,
Read More- « Previous
- 1
- 2
- 3
- 4
- Next »